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1. Introduction 
 
 Although new-generation cancer medicines provide good 
alternatives to conventional cytotoxic compound-based chemotherapy, 
the worldwide mortality data on cancerous diseases indicate that there 
is still a constant demand for new therapeutic strategies and for novel 
pharmaceutical agents to overcome cancer. Due to revolutionary 
improvements in numerous nanotechnological methods, today it seems 
possible to develop nano-sized materials for clinical applications as 
well. Metal nanoparticles represent one of the major classes of 
nanomaterials, and owing to their unique phyisco-chemical nature they 
provide an ideal platform for the development of therapeutically useful 
anti-cancer agents. While silver-based nanoparticles trigger apoptosis 
efficiently and inhibit tumor cell growth both in in vitro and in vivo 
model systems, gold-based nanoparticles are considered as biologically 
inert moieties and their radio- and photosensitizing activities render 
them attractive therapeutic tools for cancer treatment modalities. 
Although several research groups are recently focusing on metal 
nanoparticle treatment-triggered cellular responses, it is still not exactly 
understood how the basic physical and chemical properties – such as 
particle size and chemical composition – influence the interaction of 
such nanoparticles with living organisms.  
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 To develop new treatment strategies and to identify novel 
therapeutic targets, it is indispensable to understand cancer at a 
molecular, cellular and also at tissue organization levels. During 
cancerous transformation, tumor cells accumulate numerous genetic 
alterations which allow them to proliferate in an uncontrolled fashion. 
As a result of this high genetic plasticity, cancer stem cells appear early 
in the tumor mass and constantly produce cells with novel genomic 
variations. One of the most important hallmarks of cancer cell 
development is the ability to avoid programmed cell death. Cancer cells 
generally achieve this feature by the inactivation of tumorsuppressors, 
such as p53. Normally, p53 serves as a multifunctional platform to 
detect cellular impairments, like DNA damage or stress. As a 
transcriptional activator, p53 induces the expression of various repair 
genes, the maturation of anti-proliferative miRNAs, and in case of 
severe cellular damages, p53 has the potential to initiate apoptotic cell 
death. However, cancer cells without functional p53 can respond to 
apoptotic stimuli with survival, rendering the chemotherapeutic 
elimination of malignant cells rather challenging.  
 Once the constantly proliferating cancer cell population is 
grounded, cancer cells establish a sophisticated communication 
network with other cells residing in the neighboring tissues. As a result 
of an intensive recruiting activity on the part of cancer cells, solid 
tumors can grow in a highly supportive microenvironment containing 
various cell types such as fibroblasts, macrophages and even 
4 
 
adipocytes. The most abundant components of the reactive tumor 
stroma are the re-programmed fibroblast cells, which support cancer 
cell proliferation via secretion of various soluble growth factors, 
exosomes and cytokines. Furthermore, owing to the secreted factors and 
the tissue remodeling activity of cancer-associated fibroblast, invasion 
of the surrounding tissues and intravasation into blood vessels is 
facilitated, which might lead to the metastatic spread of the primary 
tumor. 
  
2. Aims 
 Given the moderate success rate of conventional chemotherapy 
in p53-deficient cancer cells, we investigated whether silver 
nanoparticles have the capability to induce programmed cell death in 
both p53-expressing and p53-deficient osteosarcoma cells. We also 
wished to examine whether 5 nm sized and 35 nm sized silver 
nanoparticles induce cancer cell apoptosis via identical or different 
intracellular mechanisms. To answer these questions, we treated wild 
type p53-expressing U2Os and p53-deficient Saos-2 osteosarcoma cells 
with either 5 nm or 35 nm sized nanoparticles and we compared the 
apoptotic responses triggered by the applied nanoparticle treatments. 
 It is well established that the supportive tumor stroma has a 
determining role in both the invasive feature and the metastatic activity 
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of the malignant cancer cells. Therefore, targeting the stroma cell-tumor 
cell crosstalk seems to be a promising strategy to treat cancer and 
suppress metastasis. In line with this, we decided to investigate whether 
the presence of metallic nanoparticles in the tumor microenvironment 
influences the crosstalk between cancerous cells and tumor-associated 
fibroblasts. Furthermore, we wished to find out whether the chemical 
composition of the applied metal nanoparticles influences their effect 
on the communication network within the tumor microenvironment. 
For this, we employed in vitro tumor cell-fibroblast co-cultures and in 
vivo 4T1 metastasis animal models and investigated the effects of gold 
and silver nanoparticles in these systems. In order to reduce the toxicity, 
but in the same time exploit the unique apoptotic features of silver 
nanoparticles, moreover, to take advantage of the biocompatible nature 
of gold nanoparticles, we synthetized gold-core, silver-shell hybrid 
nanoparticles and tested their effects on the above described in vitro and 
in vivo models. 
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3. Materials and methods 
 During our investigation, we applied several in vitro based 
mono- and co-cultures of human and mouse derived cancer and 
fibroblast cells. Cells were exposed to nanoparticles or treated with 
various cytotoxic drugs. To determine cellular viability and plasma 
membrane leakage, MTT and LDH enzyme activity assays were 
performed. Cell proliferation and migration was investigated using 
BrdU incorporation and wound healing assays. Flow cytometry 
experiments were carried out to analyze the apoptotic response of the 
nanoparticle exposed cells. Caspase 3 cleavage was detected with 
immunostaining techniques and cytoplasmic Cytochrome c levels were 
quantified with western blot experiments. Cell surface attached and 
internalized nanoparticles were visualized by scanning and 
transmission electron microscopy, while epifluorescence microscopy-
based methods were used to measure changes in mitochondrial 
membrane potential. Gene expression analysis has been accomplished 
with RT-qPCR measurements and transcriptome analyses was 
performed using Illumina MiSeq platform based RNA sequencing. To 
investigate the in vivo effects of the metal nanoparticles on tumor 
growth and metastases, a 4T1 cell-based tumor model was applied in 
Balb/c mice. 
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4.  Major findings 
1. 5 nm and 35 nm sized silver nanoparticles are taken up by 
osteosarcoma cells, and induce cell death both in p53-expressing U2Os 
and in p53-defficient Saos-2 cells with comparable degree. 
2. Silver nanoparticles can trigger apoptotic cell death in the absence of 
functional p53. 
3. In U2Os cells, 5 nm and 35 nm sized silver nanoparticles stimulate 
p53 signaling.  
4. 5 nm and 35 nm sized silver nanoparticles induce mitochondrial 
dysfunction in osteosarcoma cells. 
5. In the examined osteosarcoma cells, 5 nm and 35 nm sized silver 
nanoparticles induce apoptotic cell death via the activation of identical 
molecular pathways.  
6. Silver and silver-gold hybrid nanoparticles possess higher 
cytotoxicity to cancer cells than to non-cancerous fibroblast cells. 
7. Silver and gold-silver hybrid nanoparticles decrease the proliferation, 
migration and invasion of metastatic 4T1 cells, while gold nanoparticles 
do not affect these functions. 
8. Silver and gold-silver hybrid nanoparticles suppress the cancer cell 
proliferation-promoting activity of tumor-associated fibroblast cells. 
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9. Silver and gold-silver hybrid nanoparticles induce similar 
transcriptomic changes in tumor-associated fibroblasts and decrease the 
expression of several extracellular growth factors. 
10. Locally administrated gold-silver hybrid nanoparticles suppress the 
metastatic activity of 4T1 tumors in vivo, and increase the efficacy of 
intravenous doxorubicin therapy. 
5. Discussion 
 We investigated the biological effects of different metal 
nanoparticles in p53-deficient tumor cells as well as in in vitro tumor 
stroma and in vivo metastasis models. Similarly to the results of other 
research groups, we verified that smaller, 5 nm sized silver 
nanoparticles possess higher cytotoxicity than larger counterparts. 
Additionally, we found that silver nanoparticles have the capability to 
induce apoptosis-dependent programmed cell death in the absence of 
the tumor suppressor p53. As conventional cancer therapy often fails to 
induce cell death in p53-deficient cancer cells, these results indicate the 
unique chemotherapeutic potential of such nanomaterials. We 
concluded that 5 nm and 35 nm sized nanoparticles primarily induce 
cell death through targeting of mitochondrial structure and function. 
Although we found that smaller nanoparticles are more cytotoxic, the 
mechanism of the apoptotic action of both 5 nm and 35 nm sized silver 
nanoparticles is proved to be identical. 
9 
 
 We also found, that the cytotoxic features of silver and gold-
silver hybrid nanoparticles are cell-type dependent, as we observed 
higher cytotoxicity in cancer cells than in non-cancerous fibroblasts. 
Our results indicate, that the stimulation of tumor-associated fibroblast 
cells with metal nanoparticles could be an ideal therapeutic strategy, 
since we proved that silver and gold-silver hybrid nanoparticle 
treatments suppress the cancer-cell promoting activity of such tumor-
associated fibroblasts. Our results are also supported by in vivo data, as 
we found that locally administrated gold-silver hybrid nanoparticles 
inhibit the metastatic spreading of 4T1 tumors in Balb/c mice and could 
also enhance the therapeutic efficacy of intravenously administrated 
doxorubicin therapy. By the application of the gold-silver hybrid 
nanoparticles, the unique anti-cancer potential of silver nanoparticles 
was exploited while we took advantage of the biocompatible nature of 
gold nanoparticles. We found that the active component of the tested 
gold-silver hybrid nanoparticles is the silver shell, as the 
transcriptomical profiles of silver nanoparticle- and gold-silver hybrid 
nanoparticle-treated fibroblast cells were largely similar. 
 With our work, we provide further data on the interaction of 
metal-based nanomaterials with living cells. Our results give support to 
the potential application of metal nanoparticles in the clinical practice 
of cancer treatment and strengthen the fact that these nanoparticles 
represent ideal platforms for the development of therapeutically useful 
anti-cancer agents. 
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